A study by University of Sydney scientists has discovered why patients with glioblastoma often relapse, identifying a hidden ...

Explore the potential of CKD drug ISM4808 and its role in treating chronic kidney disease through innovative research.

Explore how the future of obesity drugs starts in preclinical discovery, addressing global challenges and advancing treatment options.

Scientists have developed an experimental RNA-based drug, TY1, that repairs DNA, reduces scar tissue and could lead to new ...

Learn how Logic-gated DARPins work to activate T cells selectively in solid tumours, enhancing therapeutic outcomes.

Explore how epilepsy target SV2A interacts with anti-epilepsy drugs in groundbreaking research using cryo-electron microscopy ...

Discover how Fibulin-5 could serve as a new blood-based marker for early liver fibrosis diagnosis and potential treatment ...

Explore the innovative method for producing lung organoids aimed at enhancing treatment for respiratory diseases effectively.

Insilico Medicine has announced ISM3830, an AI-designed CBLB inhibitor that has demonstrated promising preclinical results.

RNA therapies are moving past burst-and-fade limits. New advances in circular RNA and targeted delivery could transform how we treat autoimmune disease, infections and beyond. RNA therapeutics have ...

Researchers at NYU Abu Dhabi have developed a cheap, paper-based platform that allows tumour models to be grown, frozen and stored for future cancer drug testing – called Spheromatrix. Traditional ...

Researchers at The University of Osaka have developed a new system to study human norovirus, with the hope of being able to develop vaccines and antiviral treatments faster. Norovirus is the leading ...